Thibaut Fourniols gets its Pharm.D. from the University of Paris Descartes in 2016, and its Ph.D. in pharmaceutical sciences from the University of Louvain (Belgium) in 2020. He is a former student from the school of Inserm Liliane Bettencourt. With a strong interest on innovative formulations and targeted therapies in cancer, he has specialized in nanomedicines and tumor microenvironment, with his PhD focusing on Lipid nanocapsules and cancer-associated fibroblasts. He joined EVerZom in September 2020 as the external R&D project leader, to help EverZom customers with all their extracellular vesicles related projects.
Selection of the optimal cell source for extracellular vesicles production in regenerative medicine or drug delivery
Extracellular vesicles (EVs) are vesicles secreted by cells from several biogenesis pathways. Extracellular vesicles...